Moreover, PD-L1 expression correlated with progression from MDS overt AML, and PD-L1, PDL2, PD-1 and CTLA4 was induced by treatment with hypomethylating agents (HMA) in a concentration dependent manner [46]. Here, PDCD1 is linked to acute myeloid leukemia.